tiprankstipranks
Trending News
More News >
Advertisement

DIVG - ETF AI Analysis

Compare

Top Page

DIVG

Invesco S&P 500 High Dividend Growers ETF (DIVG)

Rating:70Outperform
Price Target:
DIVG’s rating suggests it is a solid but not outstanding ETF, supported by several strong, income-focused holdings. High-quality names like Oneok, Bristol-Myers Squibb, Pfizer, Prudential Financial, and Franklin Resources contribute positively through solid financial performance, strategic growth initiatives, and attractive dividends. However, weaker holdings such as LyondellBasell and Conagra Brands, which face revenue and profitability challenges, along with some concentration in dividend-heavy, slower-growth sectors, introduce risk that tempers the overall rating.
Positive Factors
Broad Sector Diversification
The fund spreads its investments across many sectors, which can help reduce the impact if any one industry struggles.
Several Strong Top Holdings
A number of the largest positions, such as LyondellBasell, Altria, and Franklin Resources, have shown strong year-to-date performance, supporting the ETF’s overall returns.
Consistent Recent Performance
The ETF has delivered steady gains over the past month, three months, and year-to-date, indicating relatively stable recent performance.
Negative Factors
Higher-Than-Average Expense Ratio
The fund’s expense ratio is on the higher side for a passive ETF, which means more of the returns are eaten up by fees over time.
Heavy U.S.-Only Exposure
With almost all assets invested in U.S. companies, the ETF offers little geographic diversification and is highly tied to the U.S. market.
Mixed Results Among Top Holdings
Some key positions like Prudential Financial and Conagra Brands have shown weak or negative year-to-date performance, which can drag on the fund’s overall results.

DIVG vs. SPDR S&P 500 ETF (SPY)

DIVG Summary

DIVG is the Invesco S&P 500 High Dividend Growers ETF, which follows the S&P 500 High Dividend Growth Index. It focuses on large U.S. companies that have a history of steadily increasing their dividend payments. The fund holds well-known names like Pfizer and Bristol-Myers Squibb, along with firms in financials, utilities, and consumer defensive sectors. Someone might invest in DIVG to seek a mix of income from dividends and potential long-term growth, while staying diversified across many industries. A key risk is that stock prices and dividend payments can go up and down with the overall market.
How much will it cost me?The Invesco S&P 500 High Dividend Growers ETF (DIVG) has an expense ratio of 0.41%, which means you’ll pay $4.10 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it focuses on a specific niche of high dividend growth companies, requiring more specialized management.
What would affect this ETF?The DIVG ETF, focused on U.S. large-cap companies with strong dividend growth, could benefit from stable economic conditions and increased investor demand for income-generating assets, especially in sectors like Financials and Consumer Defensive. However, rising interest rates or regulatory changes in key sectors such as Utilities and Real Estate may negatively impact performance, as these industries are sensitive to borrowing costs and policy shifts.

DIVG Top 10 Holdings

DIVG leans heavily on U.S. financials and classic dividend stalwarts, with banks like KeyCorp and Truist quietly rising and helping to set the tone for the fund. Health care names are a mixed bag: Pfizer and Bristol-Myers are holding steady to rising, offering some ballast, while consumer defensive picks like Conagra feel more like dead weight lately. Energy player Oneok has been a bright spot, adding some spark, but materials name LyondellBasell has been choppy, occasionally tugging on performance rather than pushing it forward.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
LyondellBasell3.66%$355.23K$18.38B-30.70%
52
Neutral
Conagra Brands2.38%$231.53K$9.47B-20.83%
52
Neutral
Bristol-Myers Squibb2.20%$213.74K$117.30B-3.50%
78
Outperform
Pfizer2.05%$199.63K$152.26B3.68%
74
Outperform
Franklin Resources1.89%$183.47K$14.49B35.16%
74
Outperform
Altria Group1.88%$182.50K$109.38B23.78%
64
Neutral
Oneok1.87%$181.92K$50.55B-17.94%
82
Outperform
Truist Financial1.74%$169.28K$70.50B15.61%
70
Outperform
KeyCorp1.71%$166.41K$24.60B26.18%
69
Neutral
AES1.69%$164.18K$11.22B45.56%
65
Neutral

DIVG Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
33.03
Positive
100DMA
32.51
Positive
200DMA
31.57
Positive
Market Momentum
MACD
0.45
Negative
RSI
69.98
Neutral
STOCH
90.92
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DIVG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 33.72, equal to the 50-day MA of 33.03, and equal to the 200-day MA of 31.57, indicating a bullish trend. The MACD of 0.45 indicates Negative momentum. The RSI at 69.98 is Neutral, neither overbought nor oversold. The STOCH value of 90.92 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DIVG.

DIVG Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$9.62M0.39%
$98.82M0.70%
$97.02M0.60%
$96.38M0.79%
$94.63M0.30%
$87.76M0.32%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DIVG
Invesco S&P 500 High Dividend Growers ETF
34.76
4.70
15.64%
BCUS
Bancreek U.S. Large Cap ETF
ALTL
Pacer Lunt Large Cap Alternator ETF
UPSD
Aptus Large Cap Upside ETF
LVDS
JPMorgan Fundamental Data Science Large Value ETF
RWLC
Rayliant Quantitative Developed Market Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement